Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Amortizatization of Intangibles (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Amortizatization of Intangibles for 12 consecutive years, with $5000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles fell 96.67% year-over-year to $5000.0, compared with a TTM value of $272000.0 through Sep 2025, down 59.04%, and an annual FY2024 reading of $652000.0, down 6.46% over the prior year.
  • Amortizatization of Intangibles was $5000.0 for Q3 2025 at Arcadia Biosciences, down from $13000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $407000.0 in Q2 2022 and bottomed at -$540000.0 in Q3 2021.
  • Average Amortizatization of Intangibles over 5 years is $130052.6, with a median of $175000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles plummeted 177.03% in 2021, then skyrocketed 1284.62% in 2023.
  • Year by year, Amortizatization of Intangibles stood at $17000.0 in 2021, then skyrocketed by 1064.71% to $198000.0 in 2022, then fell by 18.18% to $162000.0 in 2023, then dropped by 7.41% to $150000.0 in 2024, then plummeted by 96.67% to $5000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for RKDA at $5000.0 in Q3 2025, $13000.0 in Q2 2025, and $104000.0 in Q1 2025.